MRVI Deadline: MRVI Investors with Losses in Excess of $100K Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit

NEW YORK, April 25, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline.So what: If you purchased Maravai securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ar ...